These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30085460)

  • 1. Prescription Monitoring Reduces Opioid Abuse, Deaths.
    Robertson D
    J Ark Med Soc; 2017 Jan; 113(7):156-157. PubMed ID: 30085460
    [No Abstract]   [Full Text] [Related]  

  • 2. Systematic Literature Review of Prescription Drug Monitoring Programs.
    Ponnapalli A; Grando A; Murcko A; Wertheim P
    AMIA Annu Symp Proc; 2018; 2018():1478-1487. PubMed ID: 30815193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription drug monitoring program utilization among 15 US opioid treatment programs.
    Matusow H; Rosenblum A; Parrino M
    J Subst Abuse Treat; 2018 Feb; 85():17-20. PubMed ID: 29291767
    [No Abstract]   [Full Text] [Related]  

  • 4. Combating an Epidemic of Prescription Opioid Abuse.
    Pon D; Awuah K; Curi D; Okyere E; Stern CS
    J Calif Dent Assoc; 2015 Nov; 43(11):673-8. PubMed ID: 26798885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do more robust prescription drug monitoring programs reduce prescription opioid overdose?
    Pardo B
    Addiction; 2017 Oct; 112(10):1773-1783. PubMed ID: 28009931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal Implementation of Prescription Drug Monitoring Programs in the Emergency Department.
    Elder JW; DePalma G; Pines JM
    West J Emerg Med; 2018 Mar; 19(2):387-391. PubMed ID: 29560070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The National Opioid Epidemic: Local, State, and National Responses.
    Prince JM; Seiden WB
    WMJ; 2017 Jun; 116(2):57-60. PubMed ID: 29323817
    [No Abstract]   [Full Text] [Related]  

  • 8. A Proactive Response to Prescription Opioid Abuse.
    Califf RM; Woodcock J; Ostroff S
    N Engl J Med; 2016 Apr; 374(15):1480-5. PubMed ID: 26845291
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects on patient retention after opioid weaning in an internal medicine residency clinic.
    Opperman CP; Butler MM; Stroud AK; Sun MR
    J Opioid Manag; 2018; 14(2):117-123. PubMed ID: 29733097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing The Impact Of State Policies For Prescription Drug Monitoring Programs On High-Risk Opioid Prescriptions.
    Bao Y; Wen K; Johnson P; Jeng PJ; Meisel ZF; Schackman BR
    Health Aff (Millwood); 2018 Oct; 37(10):1596-1604. PubMed ID: 30273045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits and Limits of Abuse-Deterrent Painkillers.
    Hendrikson H; Hanson K
    NCSL Legisbrief; 2016 Feb; 24(6):1-2. PubMed ID: 27032127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing extramedical use and harms of pharmaceutical opioids: the potential role of abuse-deterrent formulations.
    Degenhardt L; Larance B; Peacock A; Farrell M
    Lancet Psychiatry; 2015 Nov; 2(11):957-9. PubMed ID: 26544739
    [No Abstract]   [Full Text] [Related]  

  • 13. Abuse-deterrent formulations of prescription opioid analgesics in the management of chronic noncancer pain.
    Hale ME; Moe D; Bond M; Gasior M; Malamut R
    Pain Manag; 2016 Oct; 6(5):497-508. PubMed ID: 27050830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid misuse: containing harms.
    Peters-Watral B
    Int J Palliat Nurs; 2016 May; 22(5):213. PubMed ID: 27233007
    [No Abstract]   [Full Text] [Related]  

  • 15. Coordination of Care and Prescription Drug Monitoring Programs.
    Neimark G; Malach S; Hurford M
    Acad Psychiatry; 2017 Apr; 41(2):297-298. PubMed ID: 28168404
    [No Abstract]   [Full Text] [Related]  

  • 16. Opiod Misuse, Abuse and Addiction Part 2: Opiod Prescriber Responsibilities and Resources.
    Paul SM; Allread V
    MD Advis; 2017; 10(1):4-16. PubMed ID: 28586557
    [No Abstract]   [Full Text] [Related]  

  • 17. Tamper-resistant opioid formulations in the treatment of acute pain.
    Passik SD
    Adv Ther; 2014 Mar; 31(3):264-75. PubMed ID: 24526323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EMR implementation of default opioid prescription quantities.
    Theriault BM; Burger CF; Schlesinger JJ
    J Gen Intern Med; 2018 Nov; 33(11):1827. PubMed ID: 30054884
    [No Abstract]   [Full Text] [Related]  

  • 19. Opioid Misuse: A Global Crisis.
    Hornberger J; Chhatwal J
    Value Health; 2021 Feb; 24(2):145-146. PubMed ID: 33518020
    [No Abstract]   [Full Text] [Related]  

  • 20. The evolution of prescription drug monitoring programs.
    Ashburn MA
    Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):852-3. PubMed ID: 27222197
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.